Psychiatrists Creating New Disorders to Boost Profits for the Pharmaceutical Companies
PSYCHIATRISTS CREATING NEW DISORDERS TO BOOST PROFITS FOR THE PHARMACEUTICAL COMPANIES – From statistics being produced by the medical profession it is clear that more and more of us, including our children, are being diagnosed with some type of mental disorder.
When you look at the Pharmaceutical companies it is interesting to note that collectively they earn £13 billion worldwide each year from anti-depressants alone.
Disturbed? Well that’s not a word you should be using; in fact being overly concerned about something could lead to a diagnosis that you should be medicated.
According to figures from the UK Office for National Statistics some ¼ of the adult population quality as suffering from at least one disorder a year and this figure is growing.
Our children are also prone to psychiatric disorder issues according to many psychiatrists and in particular ADHD (Attention Deficit Hyperactivity Disorder) is rising at a rate of 15% a year in Europe alone.
How do psychiatrists determine what is and what is not a mental disorder? The truth is that many of the so-called ‘known’ disorders are simply made up. There is no actual biological evidence to support them and yet each year the psychiatrists’ bible, the Diagnostic and Statistical Manual of Mental Disorders (DSM) or its close equivalent, the International Classification of Diseases (ICD), is compiled by psychiatrists based on little or no scientific evidence.
When it comes to the practice of psychiatry there very few scientific indicators used in order to determine a particular disorder or create a new one. Go to the doctor and complain that you are unwell and you will undergo a series of tests, including blood, urine and even stool analysis in order to determine the scientific facts, proving a clear diagnosis and prescribing suitable medication.
“There are only a handful of mental disorders in the DSM known to have a clear biological cause. These are known as the organic disorders [such as epilepsy and Alzheimer’s]. These are few and far between.” Dr Spitzer, Psychiatrists
In the years since the first publication of the DSM in 1980 the book has grown significantly in its listings of mental disorders and yet only a handful of these have ever been scientifically proven to be fact.
In the later part of May 2013 the DSM is due to be republished and will contain even more classifications and diagnosis of mental disorders. In one part psychiatrists have classified ‘grief’ as a new mental disorder. According to the DSM if a person suffers from deep sadness, the feeling of loss (mainly associated when a love one dies) or crying for a period of more than two weeks then the diagnosis is that of ‘mental depression’.
Regardless to people’s state of ‘mental’ health there is no doubt that the Pharmaceutical companies are profiting from the rise in disorder cases.
In a recent study by Professor Irving Kirsch, an associate director at Harvard Medical School, he took a number of patients with diagnosed mental disorders and split them into two distinct groups and provided anti-depressants to one group and sugar-pill placebos on the other.
His findings sent a few shockwaves through the Pharmaceutical industry when he published his findings, noting; “the difference in improvement between placebo and anti-depressant groups was clinically insignificant.”
There are many medical professionals now asking why anti-depressants are so readily prescribed when the evidence for such diagnosis is scant at best and certainly where these have no real biological evidence.
When it comes to psychiatry the real benefactors are the Pharmaceutical companies. Recently a leaked document, which found its way to the Canadian Medical Association, stated; “Officials had suppressed negative results from one study because, as they said: It would be commercially unacceptable.”
From this statement alone it is clear to see that Pharmaceutical companies are more interested in the profits than they are in the health of the population. This is backed up with that evidence that in 2004 GlaxoSmithKline was issued a lawsuit in the U.S for ‘hiding’ negative finding and just two months into the lawsuit GlaxoSmithKline settled ‘out of court’ for $2.5 million. The sum paid was nothing compared to the $4.97 billion in worldwide sales from the drug in 2003 giving rise to believe that the likes of GlaxoSmithKline would continue to engage in such deceptive practices knowing that the cost of a lawsuit does not have any adverse effect on the profits it makes from such practices.
The plain truth, when it comes to depression, is that there are some people do require medication. However with the rise in the number of people that is diagnosed with being depressed it leads to the suspicion that the psychiatrists and the Pharmaceutical companies are in cahoots in just to make money and fuel the greed of its shareholders.
I am fortunate in that I have never sought the services of a psychiatrist and while I admit that I, like many, feel a little down at times I refuse to be labelled by a person that can provide no clear evidence of their diagnosis.
The information contain here comes mainly from an investigative article by the Daily Mail. You can read more on this by visiting their website – click here